Cargando…
miRNAs as Key Players in the Management of Cutaneous Melanoma
The number of treatment options for melanoma patients has grown in the past few years, leading to considerable improvements in both overall and progression-free survival. Targeted therapies and immune checkpoint inhibitors have opened a new era in the management of melanoma patients. Despite the cli...
Autores principales: | Lorusso, Celeste, De Summa, Simona, Pinto, Rosamaria, Danza, Katia, Tommasi, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072468/ https://www.ncbi.nlm.nih.gov/pubmed/32054078 http://dx.doi.org/10.3390/cells9020415 |
Ejemplares similares
-
MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis
por: Danza, Katia, et al.
Publicado: (2014) -
TGFbeta and miRNA regulation in familial and sporadic breast cancer
por: Danza, Katia, et al.
Publicado: (2017) -
miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype
por: Tommasi, Stefania, et al.
Publicado: (2016) -
microRNAs and next generation sequencing for the prognosis of the metastatic melanoma
por: Pinto, Rosamaria, et al.
Publicado: (2015) -
Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients
por: Danza, Katia, et al.
Publicado: (2014)